25.11.2010
- Genzyme Corp has met the first in a series of deadlines imposed by U.S. regulators for fixing problems at its Boston plant, a milestone that could bolster the biotech company's...
17.11.2010
- Good Together - Life is a series of chemical reactions encapsulated in a self-replicating system. Viewed from this perspective, life science disciplines including foods is...
17.11.2010
- European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...
10.11.2010
- French drugmaker Sanofi-Aventis said it has called on bid target Genzyme not to use defensive tactics to block a takeover of the U.S. biotech but to let shareholders decide on its...
29.10.2010
- Sanofi-Aventis expanded its consumer health business in China with a $520.6 million takeover, showing it remains in the market for smaller bolt-on deals as it tries to buy U.S...
28.10.2010
- Danish-listed biotech Genmab is vulnerable to a takeover due to its current low share price, and the company needs more time to develop its full potential, its chief executive told...
20.10.2010
- France's Sanofi Aventis said on Wednesday that it had received the green light from U.S. antitrust regulators to take-over the U.S. biotech Genzyme. Sanofi said that the waiting...
18.10.2010
- Sanofi-Aventis' position remains unchanged regarding a $18.5 billion hostile offer for Genzyme, Sanofi Chief Executive Chris Viehbacher told Reuters on the sidelines of the Women's...
14.10.2010
- As Sanofi-Aventis hunkers down for a long battle to buy Genzyme, the specter of a new proxy battle for control of the U.S. biotech will become an increasingly real threat...
08.10.2010
- Genzyme said that Sanofi-Aventis's chief executive had privately opened the door in September to paying as much as $80 per share for the U.S. company before going hostile with a...
